Two Legionnaires cases on the Upper East Side have prompted a city investigation. Officials warn more illnesses may be reported and urge symptomatic residents to seek care.

Federal safety officials say about 1.72 million Cuisinart grill brushes may shed metal bristles, posing an ingestion risk; Conair will offer refunds.

A CBS News video shows a Brooklyn bodega cashier ring up a vial labeled retatrutide, highlighting a booming gray market for unapproved weight‑loss peptides and safety worries.

A Stony Brook study finds blood‑based molecular signatures linking PTSD in 9/11 responders to faster biological aging and higher chronic‑disease risk.

NYSNA nurses at St. Charles delivered a 10‑day strike notice as bargaining over staffing and pay remains stalled. A potential walkout is set for July 13.

Deadline at 5 p.m. today for Essential Plan members to apply for a free AC and installation. Funding is limited and the application portal is first‑come, first‑served.

Montefiore has opened new ER beds at Mount Vernon Hospital with state capital backing. The work is part of a phased modernization meant to keep care local and shore up finances.

State officials unveiled a Center of Excellence to train clinicians and boost health equity as cannabis use becomes more common across New York.

Mount Sinai South Nassau’s Feil Family Pavilion adds nine operating rooms and expanded ICU capacity — largely paid for with Sandy recovery dollars — and could host open‑heart surgery once state regulators sign off.

New York City reported 1,791 new HIV diagnoses in 2024, a 5.4% rise from 2023, as health officials warn that federal funding cuts could worsen the trend.

A watchdog says crisis pregnancy centers are advertising they can "rule out" ectopic pregnancy after a single scan. Medical groups say diagnosis usually requires follow‑up testing.

The FDA says Inventia-made chlorthalidone 25 mg failed dissolution testing; two lots — 11,460 bottles — were recalled nationwide. Patients should consult their pharmacist before changing therapy.

A University of Georgia meta‑analysis found tirzepatide produced the largest weight loss among GLP‑1 therapies in non‑diabetic adults, but questions remain on durability and access.